Two Sigma Investments LP Sells 58,860 Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Two Sigma Investments LP decreased its holdings in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) by 23.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 193,980 shares of the company's stock after selling 58,860 shares during the period. Two Sigma Investments LP owned 0.52% of Crescent Capital BDC worth $3,728,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Franklin Resources Inc. increased its stake in shares of Crescent Capital BDC by 12.8% during the fourth quarter. Franklin Resources Inc. now owns 289,131 shares of the company's stock valued at $5,557,000 after purchasing an additional 32,852 shares in the last quarter. Condor Capital Management increased its stake in shares of Crescent Capital BDC by 4.7% during the fourth quarter. Condor Capital Management now owns 284,055 shares of the company's stock valued at $5,460,000 after purchasing an additional 12,852 shares in the last quarter. Wells Fargo & Company MN increased its stake in shares of Crescent Capital BDC by 0.5% during the fourth quarter. Wells Fargo & Company MN now owns 253,182 shares of the company's stock valued at $4,866,000 after purchasing an additional 1,210 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of Crescent Capital BDC during the fourth quarter valued at approximately $3,750,000. Finally, Denali Advisors LLC increased its stake in shares of Crescent Capital BDC by 0.5% during the fourth quarter. Denali Advisors LLC now owns 183,783 shares of the company's stock valued at $3,532,000 after purchasing an additional 855 shares in the last quarter. Institutional investors own 49.46% of the company's stock.

Crescent Capital BDC Stock Down 2.8%

Shares of CCAP traded down $0.44 on Monday, hitting $15.08. 273,964 shares of the stock traded hands, compared to its average volume of 136,586. The company has a market capitalization of $558.86 million, a PE ratio of 7.58 and a beta of 0.63. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32. The business has a 50 day simple moving average of $15.74 and a 200 day simple moving average of $17.85. Crescent Capital BDC, Inc. has a one year low of $13.54 and a one year high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last announced its quarterly earnings results on Wednesday, May 14th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.52 by ($0.07). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The firm had revenue of $42.13 million for the quarter, compared to the consensus estimate of $45.08 million. As a group, equities analysts forecast that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Monday, June 30th will be given a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 11.14%. The ex-dividend date of this dividend is Monday, June 30th. Crescent Capital BDC's dividend payout ratio (DPR) is presently 125.37%.

Analyst Upgrades and Downgrades

CCAP has been the subject of a number of analyst reports. Wall Street Zen downgraded shares of Crescent Capital BDC from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd. Keefe, Bruyette & Woods downgraded shares of Crescent Capital BDC from an "outperform" rating to a "market perform" rating and reduced their price target for the company from $18.50 to $17.00 in a research report on Friday, May 16th. Raymond James reduced their price target on shares of Crescent Capital BDC from $20.00 to $17.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Finally, Wells Fargo & Company reduced their price target on shares of Crescent Capital BDC from $16.00 to $15.00 and set an "equal weight" rating for the company in a research report on Friday, May 16th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $17.60.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.